New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Protagonist Therapeutics, Inc.
PTGX
Shape
US Flag

NASDAQ

EPS improving

EPS improving

3B

Biotechnology

Next Earning date - 06 May 2025

3B

Biotechnology

Next Earning date - 06 May 2025

38.67USD

Shape-0.01 ( -0.03%)
Market Closed (as of Feb 14, 21:00 EDT)
favorite-chart

Relative Strenght

94
favorite-chart

Volume Buzz

-45%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

36%

Quote Panel

Shape
Updated March 19, 2025
1W -0.69 % 1M 41.65 % 3M 31.41 % 1Y 88.78 %

Key Metrics

Shape
  • Market Cap

    3.35B


  • Shares Outstanding

    61.38M


  • Share in Float

    57.87M


  • Dividende

    0


  • Earning Date

    06 May 2025


  • Price Target

    54.52


  • Average Volume

    905077


  • Beta

    2.33


  • Range

    24.22-60.6


  • Industry

    Biotechnology


  • Website

    https://www.protagonist-inc.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

PTGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$92M

Shape-46%

2025-Revenue

$1.31

Shape-161%

2025-EPS

$63M

Shape-149%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Buy

Price Target

73.00(33.90%)

Number of analyst

3

Last analyst upgrade/downgrade

BMO Capital

initialise

Previous: Not converted

2024-12-05

Now: Outperform

Cowen & Co.

initialise

Previous: Not converted

2024-09-24

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.67
vs -0.43

Q2.23

arrow
arrow

N/A

-0.68
vs -0.84

Q3.23

arrow
arrow

N/A

-0.58
vs -0.64

Q4.23

arrow
arrow

+164%

0.44
vs -0.69

Q1.24

arrow
arrow

+587%

3.26
vs -0.67

Q2.24

arrow
arrow

N/A

-0.50
vs -0.68

Q3.24

arrow
arrow

N/A

-0.54
vs -0.58

Q4.24

arrow
arrow

+350%

1.98
vs 0.44

Q1.25

arrow
arrow

N/A

-0.06
vs 3.26

Q2.25

arrow
arrow

N/A

-0.57
vs -0.50

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

-100%

NA  vs 25.7M

Q2.23

arrow
arrow

-100%

NA  vs 859K

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

60M  vs NA

Q1.24

arrow
arrow

NA

255M  vs NA

Q2.24

arrow
arrow

NA

4.2M  vs NA

Q3.24

arrow
arrow

NA

4.7M  vs NA

Q4.24

arrow
arrow

+184%

170.6M  vs 60M

Q1.25

arrow
arrow

-85%

37.5M  vs 255M

Q2.25

arrow
arrow

+71%

7.1M  vs 4.2M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

+6%

0.06
vs 0.06

Q2.23

arrow
arrow

-13%

-0.13
vs 0.06

Q3.23

arrow
arrow

+5%

0.05
vs -0.13

Q4.23

arrow
arrow

+8%

0.08
vs 0.05

Q1.24

arrow
arrow

+37%

0.37
vs 0.08

Q2.24

arrow
arrow

-6%

-0.06
vs 0.37

Q3.24

arrow
arrow

-6%

-0.06
vs -0.06

Q4.24

arrow
arrow

+19%

0.19
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

155

155
vs 142

9%

Q2.23

arrow
arrow

182

182
vs 155

17%

Q3.23

arrow
arrow

146

146
vs 182

-20%

Q4.23

arrow
arrow

159

159
vs 146

9%

Q1.24

arrow
arrow

189

189
vs 159

19%

Q2.24

arrow
arrow

194

194
vs 189

3%

Q3.24

arrow
arrow

247

247
vs 194

27%

Q4.24

arrow
arrow

247

247
vs 247

NA

Earnings Growth

Latest News

PTGX

youtube.com

16 hours ago